A network-based pharmacological investigation to identify the mechanistic regulatory pathway of andrographolide against colorectal cancer.

MLA

Janani, Balakarthikeyan, et al. “A Network-Based Pharmacological Investigation to Identify the Mechanistic Regulatory Pathway of Andrographolide against Colorectal Cancer.” Frontiers in Pharmacology, vol. 13, Aug. 2022, pp. 1–15. EBSCOhost, https://doi.org/10.3389/fphar.2022.967262.

APA

Janani, B., Vijayakumar, M., Priya, K., Jin Hee Kim, Geddawy, A., Shahid, M., El-Bidawy, M. H., Al-Ghamdi, S., Alsaidan, M., Abdelzaher, M. H., Mohideen, A. P., & Ramesh, T. (2022). A network-based pharmacological investigation to identify the mechanistic regulatory pathway of andrographolide against colorectal cancer. Frontiers in Pharmacology, 13, 1–15. https://doi.org/10.3389/fphar.2022.967262

Chicago

Janani, Balakarthikeyan, Mayakrishnan Vijayakumar, Kannappan Priya, Jin Hee Kim, Ayman Geddawy, Mohammad Shahid, Mahmoud H. El-Bidawy, et al. 2022. “A Network-Based Pharmacological Investigation to Identify the Mechanistic Regulatory Pathway of Andrographolide against Colorectal Cancer.” Frontiers in Pharmacology 13 (August): 1–15. doi:10.3389/fphar.2022.967262.